Oncolytic virus immunotherapy for melanoma

Current Treatment Options in Oncology
Neal DharmadhikariHoward L Kaufman

Abstract

Melanoma is a type of skin cancer arising from melanocytes and is increasing in incidence. Although complete surgical excision of early stage lesions may be curative, metastatic melanoma continues to be a major therapeutic challenge. Advances in understanding the molecular pathways that promote tumorigenesis and the interactions between melanoma cells and the immune system have resulted in the approval of several newly targeted agents and immunotherapy strategies for the treatment of advanced disease. Oncolytic virus immunotherapy is a new approach that uses native or attenuated live viruses to selectively kill melanoma cells and induce systemic tumor-specific immune responses. A variety of viruses are now in clinical development with the attenuated oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor, known as talimogene laherparepvec, recently demonstrating an improvement in durable response rate in patients with advanced melanoma compared with granulocyte-macrophage colony stimulating factor alone. A major advantage of talimogene laherparepvec and related agents is the limited toxicity and ability to use each individual tumor as a source of antigen to generate a highly specific antitumor immune res...Continue Reading

References

Apr 29, 1999·The New England Journal of Medicine·B A GilchrestM Yaar
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R MiddletonN Thatcher
Nov 18, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M E EvansN A Wivel
Jan 11, 2003·Cancer Gene Therapy·Susan Varghese, Samuel D Rabkin
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Darren R ShafrenRichard D Barry
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard L KaufmanLouis M Weiner
Jun 7, 2005·The Journal of Clinical Investigation·Howard L KaufmanFrancesco M Marincola
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer C C HuR Charles Coombes
Jan 30, 2008·Journal of Dermatological Science·Daisuke WatanabeYukihiro Nishiyama
Mar 26, 2009·Journal of the National Cancer Institute·Nadia HowladerBrenda K Edwards
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil N SenzerJohn J Nemunaitis
Dec 10, 2009·Seminars in Oncology·Timothy W McCardleVernon K Sondak
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jul 12, 2011·Current Pharmaceutical Biotechnology·Qi-Xiang LiXiaoliu Zhang
Jul 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tae-Ho HwangDavid H Kirn
Aug 23, 2011·Journal of Surgical Oncology·David W OllilaEddy C Hsueh
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James S WilmottRichard A Scolyer
Jan 4, 2012·Clinical and Experimental Pharmacology & Physiology·Lixiang Zhao, Haiyan Liu
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
May 17, 2012·Annals of Surgical Oncology·Bin B R Kroon
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jul 12, 2012·Nature Biotechnology·Stephen J RussellJohn C Bell
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Evanthia GalanisKari Kendra
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Feb 13, 2013·Clinical and Experimental Dermatology·G W M Millington
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Aug 30, 2013·Science Translational Medicine·Stefani SprangerThomas F Gajewski

❮ Previous
Next ❯

Citations

Apr 15, 2016·EBioMedicine·Aldo PourchetIan Mohr
Mar 5, 2016·Oncoimmunology·Jonathan PolLorenzo Galluzzi
Apr 9, 2016·Oncoimmunology·Jonathan PolLorenzo Galluzzi
Oct 23, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C FranklinD Schadendorf
Dec 7, 2016·Clinical Nuclear Medicine·Matthew F CovingtonPhillip H Kuo
Feb 7, 2018·Frontiers in Immunology·Zihao XuMinghua Wu
Nov 10, 2018·Cancer Biology & Therapy·Serena MontagnaroUgo Pagnini
Mar 25, 2019·Expert Opinion on Biological Therapy·Victor Cervera-CarrasconAkseli Hemminki
May 7, 2016·BMC Medicine·Sofia FarkonaIvan M Blasutig
Aug 27, 2018·Current Oncology Reports·Claire-Audrey Y BayanYvonne M Saenger
Jun 4, 2019·Journal of Biochemical and Molecular Toxicology·Ren GuanghuiQiu Guobin
Mar 20, 2020·Biomedicines·Altijana Hromic-Jahjefendic, Kenneth Lundstrom
Aug 16, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Karly P Garnock-Jones
May 5, 2021·The Journal of Clinical Investigation·William GiblinDavid B Lombard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

The Oncologist
Igor Espinoza-Delgado
Cancer Biology & Therapy
Martina SanlorenzoSusanna Ortiz-Urda
Current Treatment Options in Oncology
M I Milowsky, D M Nanus
© 2021 Meta ULC. All rights reserved